FDA OKs ‘Game Changer’ Pretomanid for Highly Resistant TB

This post was originally published on this site

The US Food and Drug Administration (FDA) approved pretomanid today, a “major” breakthrough treatment for the most drug-resistant tuberculosis (TB) when used in combination with bedaquiline and linezolid. It is only the third TB drug approved by the FDA …

Click here to read full article